1. Home
  2. LOCL vs BDSX Comparison

LOCL vs BDSX Comparison

Compare LOCL & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Local Bounti Corporation

LOCL

Local Bounti Corporation

HOLD

Current Price

$2.66

Market Cap

54.0M

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$8.32

Market Cap

53.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOCL
BDSX
Founded
2021
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Precision Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
54.0M
53.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
LOCL
BDSX
Price
$2.66
$8.32
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
20.8K
65.6K
Earning Date
11-12-2025
11-03-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$45,978,000.00
$80,173,000.00
Revenue This Year
$36.93
$20.75
Revenue Next Year
$82.62
$25.05
P/E Ratio
N/A
N/A
Revenue Growth
31.61
22.29
52 Week Low
$1.18
$3.44
52 Week High
$5.75
$32.20

Technical Indicators

Market Signals
Indicator
LOCL
BDSX
Relative Strength Index (RSI) 54.26 57.34
Support Level $2.27 $7.24
Resistance Level $2.80 $8.69
Average True Range (ATR) 0.22 0.65
MACD 0.04 0.02
Stochastic Oscillator 74.72 83.84

Price Performance

Historical Comparison
LOCL
BDSX

About LOCL Local Bounti Corporation

Local Bounti Corp is a controlled environment agriculture company. Its business model is based on building local facilities, operated by local teams, to deliver fresh and quality produce to local communities while maintaining a limited carbon footprint. Using proprietary technology to grow leafy greens and herbs in smart greenhouses with a cultivation process that uses less water and land than conventional agriculture, free from herbicides or pesticides, it delivers products that have a longer shelf life, and are good in taste.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: